Josephs Paul 4
4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed May 22, 2024
Insider Transaction Report
Form 4
Josephs Paul
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2024-05-20−8,975→ 516,025 total - Award
Common Stock
2024-05-20+525,000→ 525,000 total - Award
Performance-Based Restricted Stock Units
2024-05-20+1,500,000→ 0 totalExp: 2029-05-20→ Common Stock (1,500,000 underlying)
Footnotes (4)
- [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
- [F2]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.
- [F4]The performance-based restricted stock units vest, if it all, based on the Issuer's achievement of certain stock prices.